Ipamorelin 10mg
Selective GH secretagogue with minimal side effects — the cleanest GHRP available.
Ipamorelin — Growth Hormone Research Profile
Within pulsatile GH research, Ipamorelin is a selective pentapeptide GHRP and ghrelin receptor agonist that stimulates GH release with high selectivity — without significantly raising cortisol, prolactin, or appetite. This clean mechanism makes it the preferred GHRP for most protocols. Paired with CJC-1295, it forms one of the most studied dual-pathway GH secretagogue combinations, producing 2–10× greater GH output than either alone.
Primary research applications for Ipamorelin include selective gh release without cortisol spike, ideal pairing with cjc-1295 for synergy, fat loss support and lean muscle, improved sleep and recovery. As a Growth Hormone compound, it is studied in the context of growth hormone, ghrp, secretagogue — areas where its mechanism of action has the most direct relevance in preclinical models.
In standard research protocols, Ipamorelin is administered at 200–300 mcg subcutaneous 2–3x daily, with a half-life of ~2 hours. This product is supplied by Phiogen as lyophilized powder with independent third-party Certificate of Analysis (COA) documentation confirming 99%+ purity and correct molecular identity on every batch. Ipamorelin 10mg is sold strictly for laboratory and educational use only — it is not FDA-approved for human therapeutic use and is not intended for human consumption, clinical application, or use in animals.
Applications & Benefits
The Anabolic Signaling Cascade
Pituitary release of growth hormone in response to GHRH + ghrelin receptor stimulation.
Hepatic IGF-1 production binds insulin-like growth factor receptors in target tissue.
Phosphatidylinositol 3-kinase cascade activates downstream survival and growth signaling.
Mammalian target of rapamycin drives ribosomal translation — the molecular endpoint of anabolic growth.
Reconstitution Calculator
Calculate exact BAC water volume and dose measurements for Ipamorelin 10mg.
For laboratory use only. This calculator is a reference tool — verify all calculations before use. Always use sterile technique with bacteriostatic water and sterile syringes.
Effectiveness Profile
Relative effectiveness scores derived from published preclinical literature across key endpoints.
Scores are qualitative aggregates from animal and in vitro studies and are not a medical claim. For educational purposes only.
Effect Timeline
Expected milestones based on published preclinical data.
First amplified GH pulses detected. Slight IGF-1 elevation begins; anabolic signaling pathways activate.
IGF-1 levels plateau at elevated baseline. Protein synthesis increases; recovery from training improves noticeably.
Lean mass accumulation measurable. Fat oxidation increases; sleep quality improvements typically reported.
Maximum body composition improvements at sustained elevated GH/IGF-1 levels. Anti-aging mechanisms fully engaged.
First amplified GH pulses detected. Slight IGF-1 elevation begins; anabolic signaling pathways activate.
IGF-1 levels plateau at elevated baseline. Protein synthesis increases; recovery from training improves noticeably.
Lean mass accumulation measurable. Fat oxidation increases; sleep quality improvements typically reported.
Maximum body composition improvements at sustained elevated GH/IGF-1 levels. Anti-aging mechanisms fully engaged.
Timelines are derived from preclinical animal studies. Individual results in laboratory settings may vary. For educational purposes only.
Ipamorelin at a Glance
Related Topics
Ipamorelin
For educational use only · Verified vendor
Available In Bundles
Quality Assurance
Related Guides
CJC-1295 No DAC 10mg
GHRH analog — stimulates natural pulsatile growth hormone release. Pairs with Ipamorelin.
CJC-1295 No DAC 5mg
CJC-1295 No DAC 5mg — entry supply for GH pulse stimulation protocols.
CJC-1295 with DAC 10mg
Long-acting GHRH analog — binds serum albumin for sustained GH elevation with weekly dosing.